loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people. .
marketwatch: "new migraine drugs have promise -- and a ,500 price tag." http://lm360.us/Conyers-brother-of-Vidaurri-from-Aruvankadu?Kuepferda=140